Skip to main content

All Clinical Trials

Northwestern Scleroderma Program Registry

View More

NU 05H6: Acute Leukemias and Map Kinase

View More

NCI 02X3: SPORE in Pancreatic Cancer Tissue Core

View More

HLA-Identical Sibling Renal Transplant Tolerance With Donor Hematopoietic Stem Cells and Campath-1H

View More

Chicago Lupus Database

View More

Characteristics of the Stretch Reflex Response in Various Joints

View More

DERMATOLOGY TISSUE ACQUISITION AND REPOSITORY

View More

NUGene: Gene-Disease Associations and Treatment Outcomes

View More

Eye Donor Program

View More

Genetics of BRCA2-related Prostate Cancer

View More

Mediators of Atherosclerosis in South Asians Living in America

View More

NU 00X3: Pathology Core Facility

View More

RTOG 0724 - A Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterecotmy

View More

Asymmetric Neurodegeneration and Language in Primary Progressive Aphasia

View More

Chemokine mechanisms in chronic pelvic pain

View More

NU 99G8: Northwestern Ovarian Cancer Early Detection and Prevention Program: A Specimen and Data Study

View More

Alzheimer's Disease Research Center

View More

Neural Mechanisms in Sensory Reception and Processing in the Healthy Adult (VA RR&D Grant # B3302K)

View More

NCI 01X1: Breast Cancer Program: Tissue and Specimen Collection Facility

View More

Peripheral Neuropathy Research Registry (PNRR)

View More

NU 04H7: Molecular Mechanisms of Disease Progression in Myeloid Malignancy

View More

A Family Study of Pragmatic Language

View More

Northwestern University The Department of Psychiatry and Behavioral Sciences, Clinical Research Program (NU CRP) Recruitment Pipeline

View More

A PHASE 3 SINGLE CENTER STUDY OF ISLET TRANSPLANTATION IN NON-UREMIC DIABETIC PATIENTS

View More

A Randomized Trial to Prevent Congenital Cytomegalovirus Infection (CMV)

View More

A Registry of Interstitial Lung Disease Patients

View More

NCI 12H13: Molecular Mechanisms of Relapse After Therapy Discontinuation in Chronic Myeloid Leukemia

View More

CENTER FOR BEHAVIORAL INTERVENTION TECHNOLOGIES (CBITs) RESEARCH SUBJECT RECRUITMENT REGISTRY

View More

Targeting Siglecs in Disease

View More

NUDB 13C03: Northwestern Brain Tumor Institute Research Database

View More

Movement Disorders Biorepository

View More

A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis (LEGACY)

View More

Healthy Control Esophageal Registry and Biorepository

View More

Neural Systems for the Dynamic Use of Memory

View More

Noninvasive Manipulation of Hippocampal-Cortical Brain Networks and Memory

View More

Development of a Kidney Cancer Patient Outcomes Database

View More

Synovial Macrophage Transcriptional Signatures for Predicting Therapeutic Efficacy

View More

HOme-based moNitORed exercise for PAD

View More

Ex vivo interactions between high-density-like nanoparticles and human blood

View More

NCI 15H01: Triad1 Regulates Myelopoiesis and Functions as a Leukemia Suppressor

View More

Low InTensity Exercise intervention in PAD: The LITE Trial.

View More

A Randomized Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation with a Short Cervix (PROSPECT)

View More

Telmisartan Plus Exercise to Improve Functioning in PAD

View More

Chronic Kidney Disease Research Biorepository

View More

Improving Outpatient Safety of Older Adults through Electronic Patient Portals

View More

LIFT: Lupus Intervention for Fatigue Trial

View More

The ENabling Reduction of low-Grade Inflammation in SEniors) Pilot Study

View More

A large-scale multicenter phase II study evaluating the protective effect of a tissue selective estrogen complex (TSEC) in women with newly diagnosed ductal carcinoma in situ.

View More

NU 15N01: Head and Neck Tissue Bank

View More

NU 15N02: Northwestern Head and Neck Cancer Registry

View More

Motivational Interviewing and Physical Activity in Parkinson’s Disease

View More

Semen quality in males with inflammatory bowel disease: Influence of medication for IBD

View More

Epidermolysis Bullosa Clinical Characterization and Outcomes Database

View More

North American Registry for Care and Research in Multiple Sclerosis (NARCRMS) Study

View More

LiveWell: A Mobile Intervention for Bipolar Disorder

View More

Efficacy of Couples-Based HIV Prevention in Vulnerable Young Men

View More

Cocoa to Improve Walking Performance in Peripheral Artery Disease: The COCOA-PAD Study

View More

MAST CELLS IN MALE CHRONIC PELVIC PAIN AND LOWER URINARY TRACT DYSFUNCTION

View More

A Phase 2, single arm, multi-center, open label trial Combining Optune with concurrent Bevacizumab in the setting of Recurrent or Progressive Meningioma

View More

NU 16B06: Investigation of Blood-Based Prognostic Biomarkers in Patients with Advanced Breast Cancer for Molecular Mechanisms Underlying Circulating Tumor Cell Clusters

View More

Evaluating the Circadian Response to Light in Delayed Sleep-Wake Phase Disorder

View More

A wearable myoelectric-computer interface to reduce muscle co-activation in acute and chronic stroke

View More

Alzheimer’s Disease Neuroimaging Initiative 3

View More

NUDB 16Z01: The OncoSET Program Database and Biobank - Combining Clinical Outcomes with Next Generation Sequencing and other Advanced Molecular Testing for Genetic Aberrations in Patients with Advanced Solid Malignancies

View More

MISCEND

View More

Improve PAD PERformance with METformin: The PERMET Trial

View More

Investigating Serum Concentrations of Mood Stabilizing Medications in Pregnancy and Postpartum

View More

Enroll-HD: A Prospective Registry Study in a Global Huntington’s Disease Cohort

View More

ELUCDITATING THE MOLECULAR MECHANISMS UNDERLYING CYP2D6 INDUCTION DURING PREGNANCY

View More

Neuromodulation and Neurorehabilitation for Treatment of Functional Deficits after mTBI plus PTSD

View More

INtervention Study In OverweiGHT Patients with COPD (INSIGHT COPD)

View More

The Role of Circadian Dysfunction in Hepatic Encephalopathy in Patients with Cirrhosis

View More

Bimanual balanced reaching with visual biofeedback

View More

Clinical Research Consortium for the Study of Cerebellar Ataxia (CRC-SCA) to Study Natural History and Genetic Modifiers in Spinocerebellar Ataxia (SCA)

View More

Partner 3 AVIV Registry

View More

Long-Term Nicotine Treatment of Mild Cognitive Impairment

View More

A Randomized Trial of Pessary in Singleton Pregnancies with a Short Cervix (TOPS)

View More

Physical activity and DNA methylation among women with high breast density

View More

Melanoma and Skin Cancer Tissue Repository

View More

Quantitative Detection of Coronary Microvascular Dysfunction in Long COVID Patients Using a Comprehensive, Rapid, Free-Breathing Cardiovascular MRI

View More

Transformative Research In Diabetic Nephropathy (TRIDENT) (SP0043185)

View More

The Role of Positron Emission Tomography and Magnetic Resonance Imaging (without Fluorodeoxyglucose or Gadolinium) in Yttrium-90 Radioembolization Treatment Planning for Patients with Liver Malignancies

View More

Genetic causes and pathogenic mechanisms of adult epilepsies

View More

NIH All of Us Research Program Precision Medicine Initiative® Precision Medicine Initiative Cohort Program Healthcare Provider Organization Enrollment Centers

View More

Clinical Database of Prostate Cancer at Northwestern University

View More

Strengthening Circadian Signals to Enhance Cardiometabolic Functions

View More

APOLLO

View More

A Natural History Observation and Registry Study of Macular Telangiectasia Type 2: The MACTEL Study

View More

(xIRB) The CHRONICLE Study: A Longitudinal Prospective Observational Study of the Characteristics, Treatment Patterns and Health Outcomes of Individuals with Severe Asthma in the United States

View More

Clinical Trial Readiness for SCA1 and SCA3

View More

CHRONIC VENOUS THROMBOSIS: RELIEF WITH ADJUNCTIVE CATHETER-DIRECTED THERAPY

View More

Mitochondrial Dysfunction and Disability in Peripheral Artery Disease

View More

Vasculitis Clinical Research Consortium (VCRC) Genetic Repository One Time DNA Protocol

View More

Evaluation of Renal Microvascular Perfusion by Contrast Enhanced Ultrasound

View More

Longitudinal Early-onset Alzheimer’s Disease Study (LEADS)

View More

Effects of device-assisted practice of activities of daily living in a close-to-normal pattern on upper extremity motor recovery in individuals with moderate to severe stroke

View More

Randomized Controlled Trial of a Mindfulness-based Intervention in a Federally Qualified Center (FQHC)

View More

Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis

View More

A Randomized, Multicenter, Double-Blind, Parallel, Active-Control Study of the Effects of Sparsentan, A Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes in Patients with Primary Focal Segmental Glomerulosclerosis

View More

A pragmatic trial of two strategies for implementing an effective eHealth HIV prevention program (Keep It Up! 3.0)

View More

Gut Microbial remodeling with Resistant Maltodextrin for motor and non-motor symptoms in Parkinson's disease: safety and tolerability study.

View More

Project 1, Adaptations of the brain in chronic pain with opioid exposure

View More

Wearable sensors and video recording for children (birth to 24 months) to monitor motor development

View More

The Collaborative, National Quality and Efficacy Registry (CONQUER)

View More

Brain pathophysiology of osteoarthritis pain

View More

AF STOP: AF Substrate as an Outcome and Predictor of successful AF ablation

View More

Real-time Wideband Cardiac MRI for Patients with a Cardiac Implantable Electronic Device

View More

PK and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

View More

The effect of inflammatory bowel disease flares on serum prostate specific antigen

View More

CalorieHarmony for Obesity

View More

CLASP IID/IIF

View More

NU 18B05: A Phase II Study of the Determinants of Transdermal Drug Delivery to the Normal and the Radiated Breast

View More

The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients with Heart Failure and Central Sleep Apnea.

View More

Characterization of the microbiome in cutaneous T cell lymphoma

View More

Northwestern TIPS Research Study

View More

A Phase 3, Multicenter, Randomized, Placebo- and Active Comparator-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Subjects ((≥6 To <18 Years of Age)

View More

A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions

View More

A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)

View More

Modulating stimuli intensity to improve clinical outcomes in aphasia treatment

View More

A Prospective, Multicenter Study of Artemis a Minimally Invasive Neuro Evacuation Device, in the Removal of Intracerebral Hemorrhage (MIND)

View More

NU MTBC 18M02: International Melanoma Tissue Bank Consortium Site at Northwestern University

View More

Alliance A041703: A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for Ph-negative CD22-positive B-lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults with Relapsed or Refractory Disease

View More

A Phase 3, Multinational, Double-Blind, Randomized, Placebo-Controlled Study of MGL-3196 (resmetirom) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Fibrosis to Resolve NASH and Reduce Progression to Cirrhosis and/or Hepatic Decompensation

View More

A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (= 70 Years of Age) with Chronic Lymphocytic Leukemia (CLL)

View More

Yttrium-90 Radiation Lobectomy: Dose Optimization and Prediction of FLR Hypertrophy to Enable Resection of Hepatic Malignancies

View More

Natural history study of ALS and other motor neuron disorders

View More

GSO 18-01 (REDUCE PAS)

View More

BTCRC HN17-111: Phase II trial of androgen deprivation therapy (ADT) and pembrolizumab for advanced stage androgen receptor-positive salivary gland carcinoma

View More

PD-inhibitor (Nivolumab) and Ipilimumab followed by nivolumab vs. VEGF TKI cabozantinib with nivolumab in metastatic untreated REnal Cell CancEr [PDIGREE]

View More

Parkinson's Disease: Intervening Early Concerning Employment (PIECE) Aims 2 and 3

View More

(xIRB) NCI CIRB NRG GY019: A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum

View More

Project 1, Adaptations of the Brain in Chronic Pain with Opioid Exposure

View More

(xIRB) NCI CIRB: Alliance A071701: Genomically-Guided Treatment Trial in Brain Metastases

View More

MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2) (Protocol #: B01-04)

View More

A Phase 1 Single- and Multiple-Ascending-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB094 Administered Intrathecally to Adults With Parkinson’s Disease (Protocol# 254PD101)

View More

Pathogenesis of Heart Failure with Preserved Ejection Fraction in Chronic Kidney Disease

View More

(xIRB) Social Processing in Remitted Adolescent Depression

View More

(xIRB) NCI CIRB ECOG-ACRIN 2182: A Randomized Phase II Study of De-Intensified ChemoRadiation for EarlyStage Anal Squamous Cell Carcinoma (DECREASE)

View More

DRUG KO-MEN-001: A Phase 1/2 First in Human Study of the Menin-MLL(KMT2A) Inhibitor KO-539 in Patients with Relapsed or Refractory Acute Myeloid Leukemia

View More

RV Ischemia & Fibrosis in CTEPH

View More

NU 19H08: Signal Transduction of Type I Interferons in Malignant Cells

View More

Randomized controlled trial assessing transperineal prostate biopsy to reduce infection complications

View More

xIRB ALLFTD: ARTFL-LEFFTDS LONGITUDINAL FRONTOTEMPORAL LOBAR DEGENERATION

View More

Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3

View More

TAMBE Pivotal AAA 17-01

View More

REPAIR-MR

View More

A PHASE II STUDY TO EVALUATE THE SAFETY AND EFFICACY OF OQL011 ON VEGFR INHIBITOR-ASSOCIATED HAND-FOOT SKIN REACTION IN CANCER PATIENTS

View More

Oxidative Markers and Efficacy in ALS/MND Phenotypes Treated with Edaravone (Loma Linda)

View More

Angiotensin II for Distributive Shock

View More

TOPAZ TRIAL OF PARKINSONS AND ZOLEDRONIC ACID A Randomized Placebo-controlled Trial of Zoledronic Acid for Prevention

View More

CPIRA-2

View More

Sensory-specific peripheral stimulation for tremor management

View More

Cure Glomerulonephropathy

View More

A Phase 1/2a Open-Label Ascending Dose Study to Evaluate the Safety and Effects of LY3884961 in Patients with Parkinson’s Disease with at Least One GBA1 Mutation (PROPEL, Protocol #: J3Z-MC-OJAA previously called PRV-PD101)

View More

The role of the cortex and brainstem in motor preparation for proximal and distal upper extremity movements

View More

NU COVID-19 MSK20H04: Examining COVID19 Course and Outcomes in Patients Previously Diagnosed with Chronic Lymphocytic Leukemia (CLL)

View More

NU FC19L02: Phase II randomized trial of carboplatin + pemetrexed + bevacizumab, with or without atezolizumab in stage IV non-squamous NSCLC patients who harbor a sensitizing EGFR mutation or have never smoked

View More

Platform Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS): A perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.

View More

Cardio-TTRansform (ION-682884-CS2)

View More

NP-SLE

View More

The Parkinson’s Progression Markers Initiative (PPMI) 2.0 Clinical - Establishing a Deeply Phenotyped PD Cohort

View More

Screening for Coronavirus Antibodies in Neighborhoods (SCAN)

View More

Immune checkpoint inhibitor-associated acute kidney injury

View More

COVID-19 and the impact on the Immune System

View More

Amplify Gait to Improve Locomotor Engagement in Spinal Cord Injury (AGILE SCI) Trial

View More

AHEAD 3-45 Study

View More

Prospective evaluation of an applied ATTR-CM Machine Learning model to a health system electronic health record (EHR)

View More

A Sequenced Strategy for Improving Outcomes in People with Knee Osteoarthritis Pain (SKOAP)

View More

African-American Social Support Effectiveness Treatment-Partners alleviating Perinatal Depression (ASSET-PPD)

View More

COVID Prevention Trials Registry

View More

Phase 1/2 trial of blood-brain barrier opening with the SonoCloud-9 implantable ultrasound device and treatment with albumin-bound paclitaxel in patients with recurrent glioblastoma

View More

Human-like Robot Controllers for Enhanced Motor Learning

View More

(xIRB) DRUG 7465-CL-202 : An Open-label, Multicenter, Multicohort, Phase 2 Study to Evaluate Enfortumab Vedotin in Subjects with Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

View More

NRG HN006: Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer

View More

COVID-19 TestUS an initiative of RADx AcceleRATeD study (Rapid Assessment of Technology for SARS-CoV-2 Detection)

View More

Impact of immunotherapy-related skin diseases on quality of life

View More

R1: Telehealth Pain Self-Management for Employed Adults (E-TIPS)

View More

DRUG CCTL019B2003I: Managed Access Program (MAP) Cohort Treatment Plan CCTL019B2003I to provide access for patients with out of specification leukapheresis product and/or out of specification manufactured tisagenlecleucel (CTL019; Kymriah®).

View More

Evaluating the EVO treatment optimized for resource constraints: Elements Vital to treat Obesity

View More

xIRB Consortium of Early Arthritis Cohorts USA (CATCH-US) -- A prospective cohort study of adults with new onset inflammatory arthritis symptoms to understand predictors of optimal outcomes

View More

(xIRB) NCI CIRB SWOG 1823: A Prospective Observational Cohort Study to Assess mRNA 371 for Outcome Prediction in Patients with Newly Diagnosed Germ Cell Tumors

View More

Tape Strip Analysis in Dermatologic Diseases

View More

(xIRB) NCI CIRB ETCTN 10276: A Phase I/II Study of M3814 and Avelumab in Combination with Hypofractionated Radiation in Patients with Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

View More

Alliance A021806: A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer

View More

OPT2MOVE

View More

Use of Glenohumeral Injections for Management of Shoulder Pain in Individuals with ALS

View More

A Prospective and Retrospective Clinical, Histological and Molecular Analysis of the Spectrum of Cutaneous Presentations in Adult Patients Admitted to the Hospital

View More

TRISCEND II

View More

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter Study Evaluating the Efficacy and Safety of Pridopidine in Patients with Early Stage of Huntington Disease

View More

High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients

View More

Serial Monitoring of Circulating Tumor Cells During Radiotherapy for Women with Non-Metastatic Breast Cancer: A Prospective Observational Cohort Study

View More

A multicenter, double-blind, randomized study to evaluate the effects of tasimelteon vs. placebo in participants with Delayed Sleep-Wake Phase Disorder (DSWPD)

View More

Glycemic Observation and Metabolic Outcomes in Mothers and Offspring

View More

(xIRB) NCI CIRB ECOG-ACRIN 8191: Phase III Study of PET-Directed Local or Systemic Therapy Intensification in Prostate Cancer Patients with Post-Prostatectomy Biochemical Recurrence

View More

Social Correlates Of Variation In Intestinal And Oral Microbiome Among Hematopoietic Stem Cell Transplant Patients: A Geographic Exploration In The City Of Chicago

View More

Depression MRI Research Study

View More

(xIRB) DRUG BB2121-EAP-001: Expanded Access Protocol (EAP) for Subjects Receiving Idecabtagene Vicleucel That Is Nonconforming for Commercial Release

View More

DRUG Q702-ONC-P1-US001 A Phase 1 Multicenter, Open-label, Dose-Escalation, Safety, Pharmacodynamic, Pharmacokinetic Study of Q702 with a Cohort Expansion at the RP2D in Patients with Advanced Solid Tumors

View More

Neural Correlates of Acute Pain Dynamics

View More

NAV3-32: A Comparison of Tc 99m Tilmanocept Quantitative Imaging with Immunohistochemical (IHC) Analysis of CD206 Expression in Synovial Tissue from Subjects Clinically Diagnosed with Rheumatoid Arthritis (RA)

View More

(xIRB) NCI CIRB NRG BN009: Phase III Trial of Salvage Stereotactic Radiosurgery (SRS) or SRS + Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for First or Second Distant Brain Relapse After Upfront SRS With Brain Metastasis Velocity >/= 4 Brain Metastases/Year

View More

A Double-Blind Placebo-Controlled, Randomized 18-Month Phase 2A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinectics of Oral UCB0599 in Study Participants with Early Parkinson’s Disease

View More

Catalyst

View More

Precision MRI of Left Atrial Fibrosis for Patients with Atrial Fibrillation

View More

Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening

View More

DAPA ACT HF-TIMI 68

View More

Stimulating neuroplasticity in TBI with acute intermittent hypoxia

View More

DRUG JCAR017-EAP-001: Expanded Access Protocol (EAP) for Patients Receiving Lisocabtagene Maraleucel That Is Nonconforming for Commercial Release

View More

xIRB TRC-PAD Program: In-Clinic Trial-Ready Cohort

View More

NRG GU009: Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (PREDICT-RT*)

View More

A multi-center single arm Phase II study to evaluate the safety and efficacy of genetically engineered autologous cells expressing anti-CD20 and anti-CD19 specific chimeric antigen receptor in subjects with relapsed and/or refractory diffuse large B cell lymphoma (DLBCL)

View More

PLS Natural History Study (PNHS)

View More

Web-based Automated Imaging Differentiation of Parkinsonism

View More

MRI vs Echo: MR-TR

View More

(xIRB) NCI CIRB ETCTN 10285: Phase 1/2 Study of an EZH2 Inhibitor (Tazemetostat) in Combination with Dual BRAF/MEK Inhibition in Patients with BRAF- Mutated Metastatic Melanoma Who Progressed on Prior BRAF/MEK Inhibitor Therapy

View More

(xIRB) NCI CIRB SWOG 1925: Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab Versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study

View More

(xIRB) NCI CIRB Alliance A011801: The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinib

View More

NU MSK20C04: PROTECT Study: A Phase II, Open-Label Trial of PROphylactic Skin Toxicity ThErapy with Clindamycin and Triamcinolone in Glioblastoma Patients Treated with Tumor Treating Fields

View More

(xIRB) NU MC21B02: Phase IIB Randomized Trial of Oral Tamoxifen vs. Topical 4-hydroxytamoxifen gel vs. Control in Women with Atypical Hyperplasia or Lobular Carcinoma In Situ

View More

(XIRB) Drug R5668-ONC-1938: Phase 1/2 Study of REGN5668 (MUC16 X CD28, a Costimulatory Bispecfic) Administered in Combination with Cemiplimab OR REGN4018 (MUC16 X CD3)

View More

(xirb) Drug BGB-11417-101: A Phase 1/1b Open-Label Dose Escalation and Expansion Study of Bcl-2 Inhibitor BGB-11417 in Patients with Mature B-Cell Malignancies

View More

Health Literacy and Cognitive Function among Middle-Aged Adults: The MidCog Study

View More

Robotic Interventions for Spasticity Treatment

View More

Training Swallowing Initiation during Expiration: Impact on Safety and Efficiency Following Treatment for Oropharyngeal Head and Neck Cancer

View More

(xIRB) DRUG MORAb 202-G000-201: A Multicenter, Open-Label Phase 1/2 Trial Evaluating the Safety, Tolerability, and Efficacy of MORAb-202, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC) in Subjects With Selected Tumor Types

View More

A5386: Il-15 Superagonist with and without bNAbs to induce HIV control

View More

XIRB A randomized, two-arm, placebo-controlled, participant and investigator-blinded study investigating the efficacy, safety and tolerability of DFV890 in patients with symptomatic knee osteoarthritis

View More

xIRB Evaluation of Applaud Medical’s Acoustic Enhancer with Laser Lithotripsy in the Treatment of Urinary Stones

View More

NU 21B01: Volumetric Lumpectomy Specimen Image Visualization for Intraoperatively Directing Cavity Shaves, a Phase II Study (VIVID)

View More

The PROMISE Study: PROspective study of Mothers’ and Infants’ Social and Epidemiologic determinants of health

View More

COAST

View More

CY6022

View More

A Phase 3 Randomized, Placebo-Controlled Trial With a Longitudinal Natural History Run-In and Open-Label Extension to Evaluate BIIB067 Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation

View More

A phase 1, open-label, safety and dosing study of autologous desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in subjects with active, anti-DSG3, mucosal-dominant pemphigus vulgaris

View More

A Prospective, Randomized Controlled Trial Investigating Pecs Blocks Types I and II as a Method for Administering the Non-Opioid Anesthetic Exparel in Order to Mitigate Postoperative Pain, Narcotic Usage and Hospital Stay in Patients Undergoing Implant-Based Tissue Expander Breast Reconstruction Surgery.

View More

PROTECT IV Trial

View More

Clinical Trial of Approaches to Prostate Cancer Surgery

View More

IMPACT-Pain-RA

View More

LUX-Dx TRENDS

View More

NU 20H09: Phase II, Single-arm, Open-label, Multicenter study Evaluating the Efficacy of Adjunctive Zanubrutinib and CAR T-cell therapy in Aggressive B-cell Non-Hodgkin’s Lymphoma

View More

NU SARC041

View More

A PHASE IIB, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAVENOUS PRASINEZUMAB IN PARTICIPANTS WITH EARLY PARKINSON'S DISEASE

View More

SKIP-Arthralgia

View More

VIVA MIND Study

View More

A Phase 3 Study of Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

View More

NU 21C01: A phase 1/1b adaptive dose escalation study of mycophenolate mofetil (MMF) in combination with standard of care for patients with glioblastoma

View More

Testing of bevacizumab, erlotinib, and atezolizumab in combination for advanced-stage kidney cancer

View More

PROMOTER

View More

Investigation of Sleep and Health Outcomes in Women Reporting Normal and Heavy Menses Flow

View More

Drug BNT152-01C: Phase I, first-in-human, open-label, dose escalation trial to evaluate safety, pharmacokinetics, pharmacodynamics, and anti-tumor activity of BNT152+153 in patients with solid tumors

View More

NRG GU010: PARALLEL PHASE III RANDOMIZED TRIALS OF GENOMICRISK STRATIFIED UNFAVORABLE INTERMEDIATE RISK PROSTATE CANCER: DE-INTENSIFICATION AND INTENSIFICATION CLINICAL TRIAL EVALUATION (GUIDANCE)

View More

Veri-T Study

View More

Impella BTR EFS

View More

Phase II Multicenter Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

View More

RADIANCE Continued Access Protocol (RADIANCE CAP)

View More

REBIRTH